Navigation Links
New Research Provides Insight Into How Doctors View Effectiveness, Quality and Safety of Generic Medications
Date:1/11/2011

WOONSOCKET, R.I., Jan. 11, 2011 /PRNewswire/ -- A new study by researchers at Harvard, Brigham and Women's Hospital and CVS Caremark finds that 23 percent of doctors' have negative perceptions of the effectiveness and quality of generic drugs and that may lead to doctors prescribing unnecessarily expensive medications. In a study published in the Annals of Pharmacotherapy, the researchers said, "Overall, we found that the majority of physicians are comfortable with the efficacy of generic medications and are comfortable using generics themselves. However, there is a meaningful proportion who express concerns about generics . . . These beliefs could represent an important barrier to greater generic use and could contribute to elevated prescription costs for patients, insurance providers and society."

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

Lead author of the study William Shrank, MD, MSHS, of Brigham and Women's Hospital and Harvard said, "While there are many studies about how consumers and patients view generics, we thought it would be important to also look at the perception of generics by prescribers, because understanding the physician's perception can help us determine if there are other potential barriers to the greater use of generics. We don't have clear insight as to what might influence a prescriber's behavior, and as we look to develop programs to encourage more cost-effective pharmacy care, this is an area industry and policy makers should be reviewing. We know that if we help patients access less expensive medications, they are more likely to take them."  

The researchers surveyed more than 2,700 physicians and received 506 responses from prescribers representing both specialists and general practitioners. More than 60 percent of the physicians surveyed were between 35 and 54 with physicians over 55 representing about 30 percent of the survey group; physicians aged 25 to 34 made up 9 percent of the respondents.

Physicians 55 or older were 3.3 times more likely to have negative perceptions about generics than those between 25 and 34.  While the doctors said they were aware some patients struggle with the costs of medications, there was little relationship between the doctor's perception of cost burden and their perceptions of generics, the researchers said.

In addition, when asked how they are informed about the market entry of a generic medication, 75 percent said they receive their information from the pharmaceutical representatives. Other sources of information included medical journals (42 percent), colleagues (40 percent) and pharmaceutical mailings and literature (38 percent).

The researchers also said that the study is limited by the sample that was surveyed. While the sample was drawn from a large source, the response rate was low; physicians who did respond may have differed from the overall population.  

"Payors and policy makers attempting to stimulate cost-effective medication use should consider educating physicians, particularly older ones, to improve their comfort with generics," said study concludes.

The study is a product of CVS Caremark's previously announced three-year collaboration with Harvard University and Brigham and Women's Hospital to research pharmacy claims data to better understand patient behavior, particularly around medication adherence.

About CVS CaremarkCVS Caremark is the largest pharmacy health care provider in the United States. Through our integrated offerings across the entire spectrum of pharmacy care, we are uniquely positioned to provide greater access, to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 64,000 pharmacies, including approximately 7,100 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical expertise includes one of the industry's most comprehensive disease management programs. General information about CVS Caremark is available through the Company's Web site at http://info.cvscaremark.com.Media Contact:Jon SandbergCVS Caremark(401)770 4914jlsandberg@cvs.com
'/>"/>

SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer
2. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
3. Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry
4. ReSearch Pharmaceutical Services to be Acquired by Warburg Pincus
5. Topical China Industries Research Reports Published at MarketPublishers.com
6. Cannabis Science Forms Military Advisory Board That Will Be Comprised of Distinguished Military Leaders, Military Health Care Providers, Researchers and Educators Headed Up by Lieutenant Colonel, U.S. Army (Ret) Kevin Sullivan
7. Research from Best Practices, LLC Delivers Effective Market Education Tactics and Strategies for New Oncology Products
8. An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety
9. Drug Combinations That May Cause Major Drug Interactions Common Among Seniors Who Take Antidepressants, According to Thomson Reuters Research
10. Christopher Codeanne Appointed Chief Financial Officer of Premier Research Group
11. New Topical Research Reports by iData Research Published by MarketPublishers.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):